[Follow-up imaging in children with rhabdomyosarcoma: less scans, the same yield]

Bas Vaarwerk1,2, Rick R van Rijn3, Johannes H M Merks4

  • 1Amsterdam UMC, Emma Kinderziekenhuis, afd. Kinderoncologie, Amsterdam.

Insights

Frequent imaging for rhabdomyosarcoma relapse detection in children had limited clinical value. Most relapses were identified by symptoms, leading to revised guidelines with 50% fewer imaging exams and a 2-year follow-up period.

Area of Science:

  • Pediatric Oncology
  • Radiology
  • Clinical Trial Design

Background:

  • Children with rhabdomyosarcoma undergo regular follow-up imaging to detect relapses.
  • The clinical utility of frequent imaging in rhabdomyosarcoma follow-up requires evaluation.

Purpose of the Study:

  • To assess the clinical value of radiologic imaging in detecting rhabdomyosarcoma relapse.
  • To inform updated follow-up guidelines for pediatric rhabdomyosarcoma patients.

Main Methods:

  • Retrospective analysis of imaging and clinical data in rhabdomyosarcoma patients.
  • Evaluation of relapse detection rates via imaging versus clinical symptoms.
  • Development and implementation of a new follow-up protocol.

Main Results:

  • The majority of rhabdomyosarcoma relapses were detected through clinical symptoms, not imaging.
  • Frequent imaging protocols showed limited additional diagnostic value for relapse detection.
  • A revised follow-up guideline was successfully implemented, reducing imaging frequency by 50%.

Conclusions:

  • Clinical surveillance is paramount for rhabdomyosarcoma relapse detection in children.
  • Reduced frequency of imaging in follow-up protocols is feasible and effective.
  • Updated European guidelines now incorporate these findings, optimizing patient care and resource allocation.